.avif)
.avif)
We’re transforming bone health with precision vibration therapy—rooted in biomechanics and NASA research.
Osteoboost is built on proven science showing that gentle, targeted mechanical stimulation can help maintain and strengthen bones. Inspired by NASA research and refined through clinical studies, our therapy delivers safe, effective signals to support bone density—without drugs or invasive procedures.
Advancing bone health through gold-standard clinical research
Osteoboost was tested in a randomized, double-blind, sham-controlled trial—the highest standard in research—and showed significant reductions in bone loss.
85% reduction in vertebral bone density loss
Participants who used Osteoboost at least 3 times per week saw an 85% reduction in loss of vertebral bone density after 12 months, compared to the placebo group.
83% reduction in vertebral bone strength loss
Participants who used Osteoboost at least 3 times per week saw an 83% reduction in loss of vertebral bone strength after 12 months, compared to the placebo group.
Clinically proven.
Now FDA-cleared.
Osteoboost is the first and only non-drug, prescription device cleared by the FDA to treat low bone density in postmenopausal women.
First-of-its-kind clearance The only wearable device FDA-cleared to treat osteopenia using precision mechanical stimulation
Proven through gold-standard research FDA clearance was based on our randomized, double-blind, sham-controlled trial funded by the NIH
Expanding treatment options Providers and patients now have a clinically-proven, non-drug option for preserving bone strength
Accessible with a prescription Available by prescription, making it easy for women to start clinically validated treatment from home
